ATE399556T1 - Transfusionszubereitung zur peripheren intravenösen verabreichung und verfahren zur stabilisierung von vitamin b1 - Google Patents
Transfusionszubereitung zur peripheren intravenösen verabreichung und verfahren zur stabilisierung von vitamin b1Info
- Publication number
- ATE399556T1 ATE399556T1 AT04733089T AT04733089T ATE399556T1 AT E399556 T1 ATE399556 T1 AT E399556T1 AT 04733089 T AT04733089 T AT 04733089T AT 04733089 T AT04733089 T AT 04733089T AT E399556 T1 ATE399556 T1 AT E399556T1
- Authority
- AT
- Austria
- Prior art keywords
- infusion
- intravenous administration
- peripheral intravenous
- transfusion preparation
- stabilizing vitamin
- Prior art date
Links
- 230000002093 peripheral effect Effects 0.000 title abstract 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 title abstract 2
- 238000001990 intravenous administration Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 title 1
- 238000001802 infusion Methods 0.000 abstract 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 238000005192 partition Methods 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003145353 | 2003-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE399556T1 true ATE399556T1 (de) | 2008-07-15 |
Family
ID=33475233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04733089T ATE399556T1 (de) | 2003-05-22 | 2004-05-14 | Transfusionszubereitung zur peripheren intravenösen verabreichung und verfahren zur stabilisierung von vitamin b1 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060211631A1 (de) |
| EP (1) | EP1632233B1 (de) |
| JP (1) | JP4594232B2 (de) |
| KR (1) | KR101039224B1 (de) |
| CN (1) | CN100486579C (de) |
| AT (1) | ATE399556T1 (de) |
| AU (1) | AU2004241840B2 (de) |
| CA (1) | CA2526208C (de) |
| DE (1) | DE602004014760D1 (de) |
| TW (1) | TWI331043B (de) |
| WO (1) | WO2004103375A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI319984B (en) * | 2003-06-06 | 2010-02-01 | Sterile combined preparation | |
| JP5554466B2 (ja) * | 2004-03-01 | 2014-07-23 | 味の素株式会社 | 抗ヒトＴＮＦ−α抗体活性低下抑制剤 |
| JP4894219B2 (ja) * | 2004-10-15 | 2012-03-14 | ニプロ株式会社 | ビタミンｂ群配合末梢静脈栄養輸液 |
| AU2011202871B2 (en) * | 2005-08-24 | 2014-06-12 | Cumberland Pharmaceuticals Inc. | Acetylcysteine composition and uses therefor |
| US8148356B2 (en) * | 2005-08-24 | 2012-04-03 | Cumberland Pharmaceuticals, Inc. | Acetylcysteine composition and uses therefor |
| WO2007055312A1 (ja) * | 2005-11-10 | 2007-05-18 | Mitsubishi Tanabe Pharma Corporation | ピラゾロン化合物含有水溶液が充填されたプラスチック容器 |
| JPWO2008146732A1 (ja) * | 2007-05-25 | 2010-08-19 | 味の素株式会社 | 末梢静脈投与用輸液 |
| JPWO2008146731A1 (ja) * | 2007-05-25 | 2010-08-19 | 味の素株式会社 | 末梢静脈投与用輸液の製造方法 |
| AU2013207545B2 (en) * | 2008-07-07 | 2015-06-18 | Pentec Health, Inc. | Nutritive compositions and methods of using same |
| KR20110038051A (ko) * | 2008-07-07 | 2011-04-13 | 펜텍 헬스 인코포레이티드 | 영양 조성물 및 이의 사용 방법 |
| JPWO2010104023A1 (ja) * | 2009-03-11 | 2012-09-13 | 味の素株式会社 | ビタミンｂ１を安定に配合した糖液を含む末梢静脈投与用輸液 |
| JP5774603B2 (ja) * | 2010-01-04 | 2015-09-09 | ペンテック ヘルス， インコーポレイテッド | 栄養組成物およびその使用方法 |
| EP2567700B1 (de) * | 2010-05-07 | 2016-04-20 | Ajinomoto Co., Inc. | Vitaminhaltige nährstoffinfusion zur verabreichung über eine periphere vene |
| MY157108A (en) * | 2010-11-29 | 2016-05-03 | Otsuka Pharma Co Ltd | Infusion preparation |
| CN105412896B (zh) * | 2016-01-06 | 2021-08-31 | 鲁南制药集团股份有限公司 | 一种避免安神补脑液中维生素b1含量下降的方法 |
| US12419850B1 (en) | 2024-03-21 | 2025-09-23 | GanD, Inc. | Bioactive fluid compositions |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5916817A (ja) * | 1982-07-16 | 1984-01-28 | Eisai Co Ltd | アミノ酸輸液 |
| JPH06312923A (ja) * | 1993-04-30 | 1994-11-08 | Green Cross Corp:The | 末梢静脈投与用栄養輸液 |
| JP2990686B2 (ja) * | 1994-11-17 | 1999-12-13 | 田辺製薬株式会社 | 水溶性ビタミンｂ類配合総合輸液 |
| JPH0959150A (ja) * | 1995-08-11 | 1997-03-04 | Roussel Morishita Kk | 経静脈用輸液製剤 |
| JP3824716B2 (ja) * | 1996-09-17 | 2006-09-20 | 株式会社大塚製薬工場 | 中心静脈投与用輸液 |
| JP3771644B2 (ja) * | 1996-09-17 | 2006-04-26 | 株式会社大塚製薬工場 | 末梢静脈投与用輸液 |
| JP4178563B2 (ja) * | 1997-07-18 | 2008-11-12 | 味の素株式会社 | ２室容器入りビタミンｂ１配合栄養輸液剤 |
| JP4162306B2 (ja) * | 1997-09-25 | 2008-10-08 | 株式会社大塚製薬工場 | 中心静脈投与用輸液 |
| TW367247B (en) * | 1998-02-03 | 1999-08-21 | Otsuka Pharma Co Ltd | Storage container for Vitamin D solution and transfusion container |
| JP4767375B2 (ja) * | 1999-03-19 | 2011-09-07 | 田辺三菱製薬株式会社 | 総合輸液剤 |
| JP4101418B2 (ja) * | 1999-12-03 | 2008-06-18 | 田辺三菱製薬株式会社 | 総合栄養輸液剤 |
| US6391332B1 (en) * | 2000-04-20 | 2002-05-21 | Baxter International, Inc. | Therapeutic micronutrient composition for severe trauma, burns and critical illness |
| JP2003055195A (ja) * | 2001-08-20 | 2003-02-26 | Terumo Corp | ビタミンｂ１配合末梢静脈投与用総合輸液剤 |
| JP2006001945A (ja) * | 2005-09-01 | 2006-01-05 | Terumo Corp | ビタミンｂ１配合末梢静脈投与用総合輸液剤 |
-
2004
- 2004-05-14 EP EP04733089A patent/EP1632233B1/de not_active Expired - Lifetime
- 2004-05-14 CA CA2526208A patent/CA2526208C/en not_active Expired - Lifetime
- 2004-05-14 AT AT04733089T patent/ATE399556T1/de not_active IP Right Cessation
- 2004-05-14 DE DE602004014760T patent/DE602004014760D1/de not_active Expired - Lifetime
- 2004-05-14 US US10/556,772 patent/US20060211631A1/en not_active Abandoned
- 2004-05-14 WO PCT/JP2004/006539 patent/WO2004103375A1/ja not_active Ceased
- 2004-05-14 JP JP2005506329A patent/JP4594232B2/ja not_active Expired - Lifetime
- 2004-05-14 KR KR1020057021088A patent/KR101039224B1/ko not_active Expired - Lifetime
- 2004-05-14 CN CNB2004800105385A patent/CN100486579C/zh not_active Expired - Lifetime
- 2004-05-14 AU AU2004241840A patent/AU2004241840B2/en not_active Expired
- 2004-05-21 TW TW093114411A patent/TWI331043B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101039224B1 (ko) | 2011-06-03 |
| US20060211631A1 (en) | 2006-09-21 |
| EP1632233A1 (de) | 2006-03-08 |
| CA2526208A1 (en) | 2004-12-02 |
| TWI331043B (en) | 2010-10-01 |
| CN1777428A (zh) | 2006-05-24 |
| DE602004014760D1 (de) | 2008-08-14 |
| CN100486579C (zh) | 2009-05-13 |
| EP1632233B1 (de) | 2008-07-02 |
| CA2526208C (en) | 2011-11-08 |
| TW200501931A (en) | 2005-01-16 |
| WO2004103375A1 (ja) | 2004-12-02 |
| AU2004241840A1 (en) | 2004-12-02 |
| EP1632233A4 (de) | 2006-05-31 |
| KR20060015584A (ko) | 2006-02-17 |
| AU2004241840B2 (en) | 2010-02-25 |
| JP4594232B2 (ja) | 2010-12-08 |
| JPWO2004103375A1 (ja) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE399556T1 (de) | Transfusionszubereitung zur peripheren intravenösen verabreichung und verfahren zur stabilisierung von vitamin b1 | |
| KR890002948B1 (ko) | 수액제의 갈변 방지방법 | |
| ATE84414T1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus. | |
| DE58905835D1 (de) | Vorrichtung zur nadellosen, subkutanen Injektion von Medikamenten. | |
| IE872799L (en) | Peptide preparation | |
| MY114009A (en) | Total parenteral nutrition solution containing water- soluble vitamin b | |
| DK304288A (da) | Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumgangsaktivitet af et protein med vaevs-plasmino-genaktivator (t-pa)-aktivitet og anvendelse af en oploesning, der indeholder protein med t-pa-aktivitet | |
| EP1479393A4 (de) | Stabilisierte albumin-zubereitungen | |
| Lo et al. | Interaction of human hemoglobin with adenine nucleotides | |
| SE9300105D0 (sv) | Stable protein solution | |
| KR880012235A (ko) | 정상 포유동물의 헤마토크릿을 증가시키는 방법 | |
| Oertel et al. | A simple method for the determination of articaine and its metabolite articainic acid in dentistry: application to a comparison of articaine and lidocaine concentrations in alveolus blood | |
| Traylor et al. | Reactivity of ferrous heme proteins at low pH. | |
| Gillette et al. | Preliminary clinical trials with cyanate | |
| Singh et al. | Transport of gases in Pulmonary capillaries—a computation of equilibrium constants arising in the oxygen dissociation curve | |
| Sutoo et al. | The mechanism by which calcium reduces blood pressure | |
| MXPA00006934A (es) | Uso de derivados de hemoglobina para determinar el volumen plasmatico y/o sanguineo. | |
| JP2796725B2 (ja) | 綜合栄養輸液製剤及び輸液製剤用バツグ | |
| RU99114404A (ru) | Способ лечения увеитов | |
| CN101204371A (zh) | 一种注射用维生素c钠水针及其制备方法 | |
| Elia | History of parenteral nutrition. | |
| Langbroek et al. | Changes in Arterial Carbon Dioxide Tension and Arterio-Venous Difference in Oxygen Content with pH during Metabolic Acidosis | |
| Otsuki et al. | Regulatory effects of blood constituents on the function and metabolism of the cat brain in perfusion ezperiments. Brain perfusion with artificial blood containing low molecular dextran and amino acids | |
| SU1711069A1 (ru) | Способ отбора препаратов, улучшающих кислородное снабжение мозга | |
| SU897246A1 (ru) | Средство дл лечени гипокалиемии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |